Kathryn Moffett
Pediatric Infectious Diseases · Morgantown, WVNPI 1023132750
Payments from drug & device makers
Across 136 payments — averaging $3602.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vertex$355K
- Merck$58K
- Tetraphase Pharmaceuticals, Inc.$32K
- Janssen Research & Development, LLC$21K
- Sanofi Pasteur Inc.$12K
- Gilead$7K
- plus $5K from 7 others
What the payments were for
- Travel & lodging$6,83989%
- Food & beverage$87411%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vertex | 24 | $354,529 |
| Merck | 54 | $58,164 |
| Tetraphase Pharmaceuticals, Inc. | 12 | $31,702 |
| Janssen Research & Development, LLC | 9 | $21,145 |
| Sanofi Pasteur Inc. | 14 | $11,871 |
| Gilead | 8 | $7,060 |
| AbbVie(2 entities) | 7 | $4,061 |
| Vivus LLC | 2 | $603 |
| Melinta Therapeutics, LLC | 1 | $583 |
| Insmed, Inc. | 1 | $95 |
| Amgen | 1 | $34 |
| Advanced Respiratory, Inc | 2 | $20 |
| Digestive Care, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ZERBAXA$5,784
- NO PRODUCT DISCUSSED$1,228
How this compares
Too few pediatric infectious diseases providers in West Virginiato place this figure against a meaningful peer group, so we don't.
Other pediatric infectious diseases in Morgantown
- Martin WeisseMorgantown$94
- Raheel KhanCharleston$10K
- Inas Al AttarPrinceton$854
- Jacob KilgoreHuntington$125
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.